Related references
Note: Only part of the references are listed.F-18-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: A systematic review
Teruhiko Terasawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
The role of FDG-PET scans in patients with lymphoma
Pamela Seam et al.
BLOOD (2007)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis
Alexander Greb et al.
CANCER TREATMENT REVIEWS (2007)
Respective prognostic values of germinal center phenotype and early 18fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma
Jehan Dupuis et al.
HAEMATOLOGICA (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Early therapeutic response assessment by 18 FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P. Ng et al.
LEUKEMIA & LYMPHOMA (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
A unification of models for meta-analysis of diagnostic accuracy studies
Roger M. Harbord et al.
BIOSTATISTICS (2007)
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease
Lale Kostakoglu et al.
CANCER (2006)
Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study
Christophe Fruchart et al.
LEUKEMIA & LYMPHOMA (2006)
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease
Solene Querellou et al.
ANNALS OF HEMATOLOGY (2006)
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients
P. L. Zinzani et al.
ANNALS OF ONCOLOGY (2006)
Meta-analysis of diagnostic and screening test accuracy evaluations: Methodologic primer
Constantine Gatsonis et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings et al.
BLOOD (2006)
State-of-the-art therapeutics: Diffuse large B-cell lymphoma
B Coiffier
JOURNAL OF CLINICAL ONCOLOGY (2005)
State-of-the-art therapeutics: Hodgkin's lymphoma
JM Connors
JOURNAL OF CLINICAL ONCOLOGY (2005)
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
NG Mikhaeel et al.
ANNALS OF ONCOLOGY (2005)
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome
C Haioun et al.
BLOOD (2005)
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
M Hutchings et al.
ANNALS OF ONCOLOGY (2005)
Refining clinical diagnosis with likelihood ratios
DA Grimes et al.
LANCET (2005)
Sources of variation and bias in studies of diagnostic accuracy - A systematic review
P Whiting et al.
ANNALS OF INTERNAL MEDICINE (2004)
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo hodgkin lymphoma: A blinded comparison
JW Friedberg et al.
LEUKEMIA & LYMPHOMA (2004)
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma
T Torizuka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma
B Schot et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
(18)FDG positron emission tomography versus Ga-67 scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma
JM Zijlstra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen et al.
ANNALS OF ONCOLOGY (2002)